Media headlines about Cardiovascular Systems (NASDAQ:CSII) have trended somewhat positive recently, according to Accern Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cardiovascular Systems earned a news sentiment score of 0.01 on Accern’s scale. Accern also assigned news articles about the medical device company an impact score of 46.5890599756397 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Several analysts have recently commented on the stock. ValuEngine downgraded shares of Cardiovascular Systems from a “sell” rating to a “strong sell” rating in a research report on Tuesday. BidaskClub upgraded shares of Cardiovascular Systems from a “sell” rating to a “hold” rating in a research report on Monday, April 9th. Zacks Investment Research downgraded shares of Cardiovascular Systems from a “buy” rating to a “hold” rating in a research report on Monday, February 12th. Finally, Leerink Swann decreased their price objective on shares of Cardiovascular Systems from $31.00 to $30.00 and set an “outperform” rating on the stock in a research report on Thursday, February 8th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and one has assigned a buy rating to the company. Cardiovascular Systems currently has a consensus rating of “Hold” and a consensus target price of $27.00.

How to Become a New Pot Stock Millionaire

Shares of CSII stock opened at $22.69 on Tuesday. The firm has a market cap of $760.37, a PE ratio of 756.33 and a beta of 2.15. Cardiovascular Systems has a one year low of $20.58 and a one year high of $33.11. The company has a debt-to-equity ratio of 0.17, a quick ratio of 4.13 and a current ratio of 4.65.

Cardiovascular Systems (NASDAQ:CSII) last announced its quarterly earnings data on Wednesday, February 7th. The medical device company reported ($0.01) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.04) by $0.03. The firm had revenue of $52.63 million for the quarter, compared to the consensus estimate of $53.39 million. Cardiovascular Systems had a negative net margin of 1.62% and a negative return on equity of 0.50%. The company’s revenue was up 5.2% on a year-over-year basis. During the same period last year, the firm earned $0.03 EPS. equities analysts forecast that Cardiovascular Systems will post -0.07 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This piece was reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at

About Cardiovascular Systems

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.

Insider Buying and Selling by Quarter for Cardiovascular Systems (NASDAQ:CSII)

Receive News & Ratings for Cardiovascular Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems and related companies with's FREE daily email newsletter.